Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6638-6650
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6638
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6638
PLB at two years after LDLT (n = 89) | PLB at five years after LDLT (n = 55) | |
Recipient characteristics at LDLT | ||
Gender | Male 37, female 52 | Male 20, female 35 |
Age (mo) | 22 (0-234) | 19 (7-198) |
Body weight (kg) | 10.7 (2.6-58.5) | 9.7 (5.9-64.9) |
Original disease | BA 63, OTCD 9, AS 4, FHF 4, CEPS 3, graft failure 2, WD 1, PSC 1, CPS1D 1, LC 1 | BA 43, OTCD 3, AS 2, WD 2, FHF 1, HB 1, CF 1, CEPS 1, graft failure 1 |
PELD or MELD | 7.4 (-9.7-39.4) | 8.6 (-8.9-39.4) |
Operation time | 13 h 25 min (7 h 33 min-30 h 28 min) | 17h 19 min (11 h 11 min-30 h 28 min) |
Cold ischemic time | 2 h 17 min (36 min-8 h 6 min) | 2 h 06 min (25 min-16 h 19 min) |
Warm ischemic time | 45 min (30 min-2 h 2 min) | 1 h 00 min (30 min-4 h 27 min) |
Blood loss volume (mL/kg) | 77.0 (3.1-585.1) | 45.5 (6.7-776.2) |
Transfusion volume (mL/kg) | 91.3 (0.0-597.7) | 68.1 (0.0-670.7) |
Donor and graft characteristics at LDLT | ||
Gender | Father; 45, mother; 44 | Father; 30, mother; 25 |
Age (yr) | 33 (23-57) | 33 (23-53) |
ABO compatibility | Identical; 55, compatible; 20, incompatible 14 | Identical; 40, compatible; 8, incompatible 7 |
GV/SLV (%) | 68.0 (33.0-120.9) | 75.8 (35.7-121.2) |
Graft type | Lateral segment; 57, left lobe; 23, | Lateral segment; 43, left lobe; 10, |
S2 monosegment; 5, left lobe + caudate; 4 | left lobe + caudate; 2 | |
Recipient and graft characteristics at PLB | ||
Age (mo) | 48 (24-259) | 81 (68-257) |
Body weight (kg) | 15.6 (7.3-64.6) | 21.4 (14.4-71.6) |
Total bilirubin (mg/dL) | 0.63 (0.25-3.25) | 0.68 (0.26-2.55) |
AST (IU/L) | 30 (14-61) | 27 (10-251) |
ALT (IU/L) | 17 (9-54) | 17 (8-260) |
γ-GTP (IU/L) | 17 (6-440) | 16 (9-510) |
Hyaluronic acid (ng/mL) | 21 (9-239) | 17 (9-216) |
IgG (mg/dL) | 927 (440-2063) | 1148 (475-2961) |
GV/SLV (%) | 90.6 (70.2-126.9) | 93.0 (58.8-157.0) |
Spleen volume (mL) | 125 (0-892) | 145 (0-692) |
Trough of tacrolimus (ng/mL) | 3.4 (0-10.1) | 2.3 (0-15.5) |
- Citation: Sanada Y, Matsumoto K, Urahashi T, Ihara Y, Wakiya T, Okada N, Yamada N, Hirata Y, Mizuta K. Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation. World J Gastroenterol 2014; 20(21): 6638-6650
- URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6638.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6638